ISSN: 2381-8727

International Journal of Inflammation, Cancer and Integrative Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Int J Inflam Cancer Integr Ther 2024, Vol 11(2): 273

Harnessing the Power of Natural Killer Cells in Cancer Immunotherapy: Currenst Strategies and Future Prospects

Jitsua Usoda*
Department of Biotechnology and Drug Discovery, Okayama University, Japan
*Corresponding Author : Jitsua Usoda, Department of Biotechnology and Drug Discovery, Okayama University, Japan, Email: jitusoda@tokyo-med.ac.jp

Received Date: Apr 01, 2024 / Published Date: Apr 29, 2024

Abstract

Natural killer (NK) cells, as potent effectors of innate immunity, hold immense potential in cancer immunotherapy. This article explores the current strategies and future prospects of harnessing the power of NK cells in cancer immunotherapy. Key topics include NK cell biology, therapeutic approaches, combination strategies, challenges, and emerging technologies shaping the landscape of NK cell-based cancer treatments.

Citation: Jitsua U (2024) Harnessing the Power of Natural Killer Cells in CancerImmunotherapy: Currenst Strategies and Future Prospects. Int J Inflam CancerIntegr Ther, 11: 273.

Copyright: © 2024 Jitsua U. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top